NfL as a Potential Biomarker in ATTRv Amyloidosis - European Medical Journal

NfL as a Potential Biomarker in ATTRv Amyloidosis

Neurology
Download PDF

Infographic: NfL as a Potential Biomarker in ATTRv Amyloidosis

Publication of this infographic was supported and reviewed by Alnylam Pharmaceuticals.

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally

>